Public, NASDAQ:NBIX
NASDAQ Global Select Market
Neurocrine Looks Well Positioned
Date: Thu, 29 Jul 2010 20:39:35 GMT
Tags:
Neurocrine Looks Well Positioned
Daily Markets - Jul 29, 2010
Daily Markets - Jul 29, 2010
In June 2010, we upgraded our rating on Neurocrine Bio (NASDAQ:NBIX) to Outperform and established a price target of $9 per share. We regard the collaboration deal with Abbott Labs (NYSE:ABT) as a ...
Neurocrine Biosciences, Inc. Q2 2010 Earnings Call Transcript
Date: Thu, 29 Jul 2010 17:13:25 GMT
Tags:
Neurocrine Biosciences, Inc. Q2 2010 Earnings Call Transcript
TheStreet.com - Jul 29, 2010
TheStreet.com - Jul 29, 2010
By Seeking Alpha 07/29/10 - 01:04 PM EDT Good day everyone, and welcome to today's program. At this time, all participants are in a listen-only mode. Later, you will have the opportunity to ask ...
Neurocrine Biosciences Guides Above Estimates
Date: Wed, 28 Jul 2010 22:10:16 GMT
Tags:
Neurocrine Biosciences Guides Above Estimates
Trading Markets - Jul 28, 2010
Trading Markets - Jul 28, 2010
Neurocrine Biosciences, Inc. (NASDAQ: NBIX | PowerRating) said it expects 2010 revenue of approximately $32.0 million. The current consensus estimate is revenue of $17.9 million for the year ...
Neurocrine Biosciences Reports Second Quarter 2010 Results
Date: Wed, 28 Jul 2010 20:06:52 GMT
Tags:
Neurocrine Biosciences Reports Second Quarter 2010 Results
PR Newswire - Jul 28, 2010
Hapoalim Securities Reiterates Buy Rating on Neurocrine Biosciences (NBIX) - Benzinga
RTT News - GuruFocus.com
PR Newswire - Jul 28, 2010
SAN DIEGO, July 28 /PRNewswire-FirstCall/ -- Neurocrine Biosciences, Inc. (Nasdaq: NBIX) today announced its financial results for the quarter ended June 30, 2010. For the second quarter of 2010 ...
Neurocrine Biosciences Q2 net loss decreases - Trading MarketsHapoalim Securities Reiterates Buy Rating on Neurocrine Biosciences (NBIX) - Benzinga
RTT News - GuruFocus.com
Neurocrine Biosciences, Inc. Issues H2 2010 Revenue Guidance Above Analysts' Estimates; Issues FY 2010 Guidance Above Analysts' Estimates
Date: Wed, 28 Jul 2010 20:05:00 GMT
Tags:
Neurocrine Biosciences, Inc. Issues H2 2010 Revenue Guidance Above Analysts' Estimates; Issues FY 2010 Guidance Above Analysts' Estimates
Reuters Key Development - Jul 28, 2010
Reuters Key Development - Jul 28, 2010
NEUROCRINE BIOSCIENCES INC Files SEC form 10-Q, Quarterly Report (EDGAR Online)
Date: Thu, 29 Jul 2010 20:31:59 GMT
Tags:
Neurocrine Looks Well Positioned (Zacks)
Date: Thu, 29 Jul 2010 19:13:31 GMT
Tags:
Neurocrine Biosciences, Inc. Q2 2010 Earnings Call Transcript (at Seeking Alpha)
Date: Thu, 29 Jul 2010 17:04:24 GMT
Tags:
NEUROCRINE BIOSCIENCES INC Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statements an (EDGAR Online)
Date: Wed, 28 Jul 2010 20:22:02 GMT
Tags:
Neurocrine Biosciences Reports Second Quarter 2010 Results (PR Newswire)
Date: Wed, 28 Jul 2010 20:05:00 GMT
Tags:
Neurocrine Biosciences, Inc. today announced its financial results for the quarter ended June 30, 2010. For the second quarter of 2010, the Company reported a net loss of $5.2 million, or $0.09 per share, compared with a net loss of $15.3 million, or $0.39 per share, for the same period in 2009.